XML 51 R33.htm IDEA: XBRL DOCUMENT v3.24.1
NATURE OF BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SCHEDULE OF CONTRACT LIABILITIES

 

   December 31, 2023 
   December 31, 2022   Additions/Reclass   Recognized Revenue   December 31, 2023 
Contract liabilities, current  $2,154,874   $2,538,187   $1,755,893   $2,937,168 
Contract liabilities, non-current   5,818,082    2,328,994    806,617    7,340,459 
                     
   $7,972,956   $4,867,181   $2,562,510   $

10,277,627 

 

 

   December 31, 2022 
   December 31, 2021   Additions/Reclass   Recognized Revenue   December 31, 2022 
Contract liabilities, current  $1,665,519   $1,478,479   $989,124   $2,154,874 
Contract liabilities, non-current   2,687,786    4,560,600    1,430,304    5,818,082 
                     
   $4,353,305   $6,039,079   $2,419,428   $7,972,956 
SCHEDULE OF SHORT TERM INVESTMENTS

Cash and cash equivalents include funds on hand, in bank and short-term investments with original maturities of ninety (90) days or less. The following table shows the Company’s cash and cash equivalents by significant investment category as of December 31, 2023 and 2022:

 

   December 31, 2023 
   Adjusted
Cost
   Realized
Gains
   Realized
Losses
   Fair Value 
Demand deposits  $545,207   $   $   $545,207 
Short-term investments with original maturities of 90 days or less (Level 1):                    
Money market funds   135,342            135,342 
                     
   $680,549   $   $   $680,549 

 

   December 31, 2022 
   Adjusted
Cost
   Realized
Gains
   Realized
Losses
   Fair Value 
Demand deposits  $897,745   $   $   $897,745 
Short-term investments with original maturities of 90 days or less (Level 1):                    
Money market funds   2,634,454            2,634,454 
                     
   $3,532,199   $   $   $3,532,199 
SCHEDULE OF RECONCILIATION OF CASH AND CASH EQUIVALENTS

The following table provides a reconciliation of cash and cash equivalents in the consolidated balance sheets to cash, cash equivalents and restricted cash in the consolidated statements of cash flows:

 

   December 31,
2023
   December 31,
2022
 
Cash and cash equivalents  $680,549   $3,532,199 
Long-term restricted cash included in other assets   97,600     
Total cash, cash equivalents and restricted cash in the statements of cash flows  $778,149   $3,532,199